GlassScriptPhysician profile
Thomas S Nabity
NPI 1669686390
$7,173.82
in general payments reported to CMS, 2019-2025
40 companies · $670 in 2025
The $670 reported for 2025 was more than what 83% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,836 · 2020: $170 · 2021: $343 · 2022: $3,019 · 2023: $792 · 2024: $344 · 2025: $670.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,806.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,805.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pinnacle, INC | $3,693.31 | 2019-2024 | |
| Nevro Corp. | $1,001.03 | 2019-2024 | Senza |
| Boston Scientific Corporation | $489.08 | 2019-2025 | General - Pain Management |
| Merz North America, INC. | $281.70 | 2019-2020 | |
| Globus Medical, INC. | $211.49 | 2025 | Senza |
| Saluda Medical Americas, INC. | $184.85 | 2023-2025 | Evoke, Evoke Scs |
| Vertical Pharmaceuticals, LLC | $113.14 | 2019-2020 | |
| Allergan, INC. | $110.51 | 2019-2021 | |
| Medtronic, INC. | $108.38 | 2021-2025 | Inceptiv |
| Abbott Laboratories | $62.55 | 2024-2025 | Proclaim |
| Bioventus LLC | $61.78 | 2019-2022 | |
| Abbvie INC. | $49.91 | 2024 | |
| Spinal Simplicity, LLC | $49.59 | 2025 | Ha Minuteman G3-R |
| Novartis Pharmaceuticals Corporation | $47.80 | 2019-2020 | |
| Grifols USA, LLC | $46.02 | 2019 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Nabity listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.